The manuscript is critically revised by XG and finally approved by all authors for publication
Supports appetite awareness Supports portion awareness Helps manage daily food habits Complements a personalized wellness routine Injections are designed for once-weekly dosing, providing steady, structured support for your daily routine as directed by your licensed provider
A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model
Semaglutide may support gradual weight loss, better appetite control and changes in some metabolic health markers over time
Your healthcare team can help determine whether an oral GLP-1 is a good fit for your weight loss goals, health history, and lifestyle
Studies have demonstrated that liraglutide significantly impairs colorectal cancer cell migration, invasion, and proliferation by inhibiting the PI3K/Akt/mTOR signaling pathway, while concurrently promoting tumor cell apoptosis [77]